The new facility will focus on the R&D of inhalation products for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases
Lupin has opened its new centre of excellence for inhalation research in Coral Springs, Florida. Local and state leaders, including Florida Lieutenant Governor Carlos Lopez-Cantera, Florida Department of Economic Opportunity Director Jesse Panuccio, and Mayor Skip Campbell, were on site to celebrate the opening of Lupin’s new facility with a ribbon cutting ceremony.
Bringing 45 highly skilled positions to Broward County, Lupin’s South Florida expansion recognises the steady growth of Florida’s life sciences industry and the economic potential it holds for the state. Lupin’s new facility will focus on the research and development of inhalation products for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases.
Vinita Gupta, Chief Executive Officer, Lupin said, “We are delighted to be making our mark in South Florida. With the talent and resources this state provides, our Coral Springs expansion will further strengthen our ability to bring quality, affordable pharmaceuticals to patients in the US and other key markets globally. The new inhalation research and development facility is a significant step forward in our journey to emerge as a global speciality pharma player.”
Carlos Lopez-Cantera, Lt Governor, Florida said, “The opening of this facility is a testament to the strength of Florida’s life sciences industry and the diverse and talented workforce who call this state home. We welcome Lupin to the Sunshine State and look forward to the incredible research and therapies that are developed as a result of their presence in Florida.”
Lupin’s Coral Springs facility was made possible through collaboration among Enterprise Florida, the Florida Department of Economic Opportunity, CareerSource Florida, Broward County and the Greater Fort Lauderdale Alliance.